| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 9.1% | -15% | $1,043,635,432 | -$181,821,806 | 17,560,751 | -15% | BlackRock, Inc. | 31 Dec 2025 |
| PRIMECAP MANAGEMENT CO/CA/ | 8.2% | $906,812,938 | 15,795,383 | PRIMECAP MANAGEMENT CO/CA/ | 30 Jun 2025 | |||
| Capital Research Global Investors | 4.8% | -29% | $576,308,252 | -$241,913,549 | 9,150,655 | -30% | Capital Research Global Investors | 31 Mar 2025 |
| VIKING GLOBAL INVESTORS LP | 4.3% | -35% | $450,729,215 | -$214,821,957 | 8,322,179 | -32% | VIKING GLOBAL INVESTORS LP | 30 Sep 2025 |
As of 31 Dec 2025, 530 institutional investors reported holding 187,369,026 shares of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN). This represents 97% of the company’s total 192,975,286 outstanding shares.
The largest institutional shareholders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.9% | 19,135,108 | -13% | 0.02% | $1,137,199,439 |
| VANGUARD GROUP INC | 9.4% | 18,127,847 | -2.4% | 0.02% | $1,077,337,946 |
| Dodge & Cox | 7.6% | 14,572,384 | -0.78% | 0.47% | $866,036,781 |
| PRIMECAP MANAGEMENT CO/CA/ | 7.5% | 14,549,314 | -4.5% | 0.65% | $864,665,732 |
| NORGES BANK | 3.9% | 7,531,080 | 0.05% | $447,572,084 | |
| STATE STREET CORP | 3.9% | 7,523,218 | -14% | 0.01% | $447,104,846 |
| AQR CAPITAL MANAGEMENT LLC | 3.5% | 6,686,916 | +13% | 0.21% | $395,196,725 |
| VIKING GLOBAL INVESTORS LP | 3.1% | 6,036,936 | -27% | 0.95% | $358,775,106 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 3,674,089 | +3.7% | 0.01% | $218,394,606 |
| DIMENSIONAL FUND ADVISORS LP | 1.7% | 3,321,754 | +48% | 0.04% | $197,404,798 |
| MILLENNIUM MANAGEMENT LLC | 1.6% | 3,037,616 | +16% | 0.13% | $180,525,519 |
| Vestal Point Capital, LP | 1.6% | 3,000,000 | +261% | 6.5% | $178,290,000 |
| Capital Research Global Investors | 1.3% | 2,547,287 | +0.38% | 0.03% | $151,385,266 |
| MORGAN STANLEY | 1.2% | 2,315,620 | +68% | 0.01% | $137,617,375 |
| Deep Track Capital, LP | 1.2% | 2,300,000 | +9153% | 3.1% | $136,689,000 |
| UBS Group AG | 1.1% | 2,211,721 | +44% | 0.03% | $131,442,578 |
| FMR LLC | 0.95% | 1,837,071 | +368% | 0.01% | $109,177,147 |
| Squarepoint Ops LLC | 0.95% | 1,828,344 | +32% | 0.22% | $108,658,484 |
| NORTHERN TRUST CORP | 0.8% | 1,547,965 | -6.9% | 0.01% | $91,995,561 |
| AMERIPRISE FINANCIAL INC | 0.76% | 1,465,198 | +19% | 0.02% | $87,076,480 |
| Qube Research & Technologies Ltd | 0.74% | 1,436,639 | +452% | 0.12% | $85,379,456 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.74% | 1,423,712 | +1.9% | 0.01% | $84,611,204 |
| Assenagon Asset Management S.A. | 0.74% | 1,419,067 | +312% | 0.13% | $84,335,152 |
| CITADEL ADVISORS LLC | 0.71% | 1,364,691 | +243% | 0.06% | $81,103,586 |
| DNB Asset Management AS | 0.7% | 1,359,549 | +6.7% | 0.28% | $80,797,997 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 187,369,026 | $11,123,555,459 | +$542,311,341 | $59.43 | 530 |
| 2025 Q3 | 179,554,894 | $9,724,648,098 | -$255,493,901 | $54.16 | 573 |
| 2025 Q2 | 184,517,274 | $10,145,314,583 | +$90,429,124 | $54.97 | 576 |
| 2025 Q1 | 181,117,177 | $12,795,609,480 | -$83,582,224 | $70.69 | 576 |
| 2024 Q4 | 183,186,403 | $12,041,547,200 | +$135,391,046 | $65.73 | 536 |
| 2024 Q3 | 180,328,429 | $12,672,555,041 | -$377,350,661 | $70.29 | 545 |
| 2024 Q2 | 184,765,128 | $15,210,183,330 | -$88,804,857 | $82.33 | 555 |
| 2024 Q1 | 186,676,383 | $16,305,278,098 | +$52,133,744 | $87.34 | 550 |
| 2023 Q4 | 185,955,477 | $17,930,401,770 | +$422,069,685 | $96.42 | 540 |
| 2023 Q3 | 181,505,269 | $16,056,450,996 | +$288,283,093 | $88.48 | 513 |
| 2023 Q2 | 178,653,463 | $15,494,286,845 | -$55,787,524 | $86.68 | 548 |
| 2023 Q1 | 179,051,547 | $17,400,388,762 | -$352,972,540 | $97.24 | 544 |
| 2022 Q4 | 182,911,512 | $18,940,963,403 | +$57,088,463 | $103.49 | 570 |
| 2022 Q3 | 182,236,184 | $15,455,338,348 | +$265,782,383 | $84.77 | 535 |
| 2022 Q2 | 179,167,298 | $14,847,543,178 | +$141,628,422 | $82.87 | 525 |
| 2022 Q1 | 177,887,694 | $13,719,376,304 | +$56,012,733 | $77.10 | 543 |
| 2021 Q4 | 177,134,050 | $15,645,638,303 | +$125,285,951 | $88.35 | 539 |
| 2021 Q3 | 175,999,345 | $13,600,848,412 | +$49,734,828 | $77.29 | 498 |
| 2021 Q2 | 176,035,547 | $14,685,174,801 | -$129,382,414 | $83.44 | 510 |
| 2021 Q1 | 177,743,163 | $13,419,458,431 | -$323,613,922 | $75.51 | 513 |
| 2020 Q4 | 182,409,125 | $15,984,411,685 | +$294,129,377 | $87.69 | 519 |
| 2020 Q3 | 179,647,602 | $13,663,308,058 | -$318,133,163 | $76.08 | 487 |
| 2020 Q2 | 180,885,676 | $22,304,634,235 | +$749,303,824 | $123.34 | 516 |
| 2020 Q1 | 176,765,627 | $14,935,321,561 | +$286,486,516 | $84.50 | 489 |
| 2019 Q4 | 173,399,113 | $14,656,072,034 | +$53,952,753 | $84.55 | 454 |
| 2019 Q3 | 173,803,512 | $11,713,783,697 | -$329,529,601 | $67.40 | 427 |
| 2019 Q2 | 178,061,150 | $15,246,971,937 | +$229,169,981 | $85.65 | 471 |
| 2019 Q1 | 178,407,022 | $15,847,079,543 | -$79,141,968 | $88.83 | 475 |
| 2018 Q4 | 179,234,022 | $15,261,762,453 | -$186,785,701 | $85.15 | 459 |
| 2018 Q3 | 180,913,922 | $17,544,279,006 | -$163,074,756 | $96.97 | 449 |
| 2018 Q2 | 182,744,905 | $17,212,623,295 | +$242,791,323 | $94.20 | 440 |
| 2018 Q1 | 180,119,807 | $14,603,106,292 | +$188,116,053 | $81.07 | 421 |
| 2017 Q4 | 177,577,894 | $15,832,679,554 | +$224,283,938 | $89.17 | 431 |
| 2017 Q3 | 174,774,741 | $16,264,630,184 | +$327,519,029 | $93.07 | 407 |
| 2017 Q2 | 171,446,875 | $15,566,292,229 | +$225,362,433 | $90.82 | 423 |
| 2017 Q1 | 169,058,166 | $14,840,823,389 | +$900,396,515 | $87.78 | 411 |
| 2016 Q4 | 169,392,815 | $14,033,179,313 | +$56,824,379 | $82.84 | 404 |
| 2016 Q3 | 168,245,764 | $15,561,381,289 | +$820,936,102 | $92.52 | 419 |
| 2016 Q2 | 159,820,679 | $12,448,675,606 | -$243,125,240 | $77.80 | 386 |
| 2016 Q1 | 162,459,664 | $13,396,780,263 | +$49,991,390 | $82.48 | 379 |
| 2015 Q4 | 161,240,868 | $16,892,503,727 | +$165,350,997 | $104.76 | 381 |
| 2015 Q3 | 159,382,647 | $16,784,552,713 | +$116,767,806 | $105.32 | 386 |
| 2015 Q2 | 157,700,975 | $21,572,249,632 | +$147,538,663 | $136.78 | 390 |
| 2015 Q1 | 156,515,480 | $19,500,401,807 | +$1,280,160,168 | $124.62 | 374 |
| 2014 Q4 | 147,645,431 | $13,350,128,993 | +$129,533,927 | $90.40 | 338 |
| 2014 Q3 | 147,667,828 | $10,655,377,287 | +$238,496,683 | $72.16 | 312 |
| 2014 Q2 | 144,555,723 | $8,993,046,726 | -$244,244,682 | $62.21 | 319 |
| 2014 Q1 | 148,047,218 | $10,094,601,533 | +$481,416,489 | $68.21 | 309 |